loader image

Global Regenerative Trade

Medical Technologies

Global Regenerative Group Becomes Global Distributor for Pharmaceutical Wholesaler Prosupplier GmbH Representing Their CureOs® Synthetic BONE GRAFT

Global Regenerative Group, developer and global distributor of new and innovative products in the
field of Regenerative Medicine, today announces its partnership with Prosupplier GmbH, a
pharmaceutical wholesaler with an experienced and specialist team, whose products include
CureOs® Synthetic BONE GRAFT.
Boca Raton, FL, August 02, 2019 –(PR.com)– Of the agreement, Prosupplier’s General Manager, Sibel
Peksen said, “We are excited to work with Global Regenerative Group, as we see in them a credible
company with big future in both business and science. Our main aim is to create a network between
companies, helping each other to develop health care around the world.” The partnership of the two
companies will provide a globally accessible international market. This way, CureOs® Synthetic BONE
GRAFT will be able to reach more physicians around the world.
“My long experience with implementation of regenerative therapies in medical practice granted me the
chance to notice that there is a great dissent in the medical practice and science. I have encountered
problems like lack of evidence of effectiveness about certain therapies, creating false claims on the
product labels, and so on. That’s the reason why partnership of the two companies is so important for us. I
think, working together, we will develop a successful business, solving these problems of our society,”
states Mihail Blagoev, Vice President of Global Regenerative Group.
CureOs® Synthetic BONE GRAFT

CureOs -TriCalcium Phosphate/Silicate Bone Grafts are synthetic, osteoconductive, 80% porous,
interconnected macroporosity and microporosity structured, resorbable and biologically compatible bone
graft substitute materials. It provides major help for bone healing process.
CureOs – TriCalcium Phosphate/Silicate Bone Grafts are used in:
General bone defects repairment, metaphysical defects repairment, reconstruction, augmentation and
filling maxillofacial region, arthrodesis and benign tumor treatment, spinal defects repairmen, sinus rifts,
filling of endodontic defects, ridge augmentation, cavity filling in bone tissue.
CureOs has an 80% porosity which enhances osteoconductivity. Micro-porosity acts as an attracting agent
to bone generating cells, which allows bone formation inside the granule. Macro-porosity promotes the
invasion of osteogenic cells by osteoconduction.
Silicate used in the CureOs, accelerates the bone formation and provides a more stable osteoconductive
scaffold. Silicate is essential for normal bone development and its level in a bone graft has a positive
effect on the healing process. CureOs Synthetic bone grafts are manufactured from Beta Tricalcium
Phosphate and is absent from any cytotoxic effects.

About Global Regenerative Group
The company provides business development for medical device companies with an emphasis on
Regenerative Medicine technologies and works extensively with clinics, hospitals and medical facilities
that are engaged in Regenerative Therapy.
Regenerative medicine is a new, evidence based, multidisciplinary approach that seeks to repair or
replace damaged or diseased human cells or tissues to restore normal function, which holds the promise
of revolutionizing patient care in the 21st century.
Global Regenerative Group was established to share groundbreaking medical technologies for use in
therapies that significantly enhance the body’s natural healing ability. During the last decade the company
has developed extensive experience in the most advanced medical device industries. In the past several
years, the company’s emphasis has been focused exclusively on Regenerative Medicine, such as stem cell
technologies, products, and therapies.
Global Regenerative Group consults with science based and reputed medical technology companies that
are startups and/or companies looking to expand and grow their business. Global Regenerative Group has
built a comprehensive network of experts in Europe, South America, Middle East, Asia and Australia.
The company also organizes and facilitates scientific conferences and workshops to lecture about the
latest developments, innovations, and breakthroughs.
About Prosupplier
Prosupplier GmbH is a pharmaceutical wholesaler located in Basel and established in 2014. They are
holding a licence for Swissmedic and they perform import and export of pharmaceuticals, cosmetics.
Even though they are a young company, thanks to their experienced and specialist team they have gained
a place in the international pharmaceutical market in a short span of time. As a Swiss company, quality is
very important for them. Their company complies with “Good Distribution Practices.” Even though they
have access to many pharmaceuticals markets around the world, they are working hard to reach more and
more in order to supply all needed products at competitive price in the shortest time.

PR.com Press Release Distribution Terms of Use

Contact Information:
Global Regenerative Group
Randy Beimel
Contact via Email
Online Version of Press Release:
You can read the online version of this press release at: https://www.pr.com/press-release/791143

Leave a Comment

Your email address will not be published. Required fields are marked *

Vivostat Logo


The uniqueness of the Vivostat® system is a novel patented biotechnological process that enables reliable and reproducible preparation of autologous Fibrin Sealant or Platelet Rich Fibrin (PRF®) without using cryoprecipitation and without the need for a separate thrombin component.


  • The Processor Unit is a non-sterile, reusable, fully automated device that controls the biochemical process.
  • The Processor Unit is used to process the patient’s blood and prepare the Vivostat® Fibrin Sealant or Vivostat PRF® solution.
Vivostat Processor Product
  • The Processor Unit is operated by a single button and a display keeps the nurse informed of the remaining process time and status at all times. No specific installation is required and the large wheelbase makes moving it easy.
  • The Processor Unit can be located in any room or corridor in the operating department. It is most often placed centrally between the operating theatres. This way one Processor Unit can supply a number of operating theatres.
  • In approx.  25 min a concentrated fibrin sealant or PRF® solution is prepared from the patient’s whole blood.
  • The Applicator Unit is a non-sterile, reusable, fully automated device that controls the delivery of the Vivostat® Fibrin Sealant or Vivostat PRF®.
Vivostat Processor Product
  • The large display and integrated microprocessor automatically primes the Spraypen® and informs the surgeon of the remaining volume of fibrin sealant/PRF® throughout the entire process.
  • Different spray modes can be selected depending on the actual procedure or area to be covered. Like the Processor Unit it has a large wheelbase and can easily be moved if required.
  • The disposable set comprises of two parts: A Preparation Kit used to prepare the fibrin sealant or PRF® solution before surgery, and an Application Kit used to activate and apply the fibrin sealant/PRF® solution.


  • Preparation Kit
    The Preparation Kit contains the specially designed Preparation Unit – a sterile disposable device in which the patient’s blood is collected, the biochemical process carried out, and the fibrin sealant or PRF® solution harvested.


  • The Application Kit
    The Application Kit contains the Spraypen®1 and all other items required to prepare the system for the delivery of the fibrin sealant or PRF® solution. The Spraypen® is a sterile, disposable, hand held device which delivers the fibrin sealant or PRF® solution to the tissue. The revolutionary and patented design offers the surgeon unparalleled freedom in controlling the application unlike any other product on the market today.


1Besides the Spraypen®, the Vivostat® system offers different types of applicators, e.g. the Endoscopic Applicator. For a full list of application devices click here

1-2-3 Spray

Three easy steps to prepare Vivostat® Fibrin Sealant or Vivostat PRF®

1. Draw blood from the Patient

Fibrin Prep With Blood Inside

At the time of surgery or up to 24 hours before1, citrate (supplied with the kit) is added to the Preparation Unit. 120 ml of the patient’s own blood is then drawn into the same unit.

2. Process the patient’s blood

Vivostat Processor 800

The Preparation Unit is placed in the Processor Unit. At the touch of a button the process starts; after approx. 25 minutes, an autologous fibrin or PRF® solution is ready for use. No thrombin or bovine components are added to the blood at any time.

3. Load the Applicator Unit and spray

Vivostat Display Applicator

The Fibrin or PRF® solution is easily loaded into the Applicator Unit and applied to the surgical site using one of the unique application devices (e.g. the Spraypen). 1This depends on the type of kit being used. Always consult the “Instructions for Use” supplied with the kit to determine the correct preparation.

The following video illustrates how to prepare and apply autologous fibrin sealant.

Presentation DVD from Vivostat A/S on Vimeo.